Baird Medical Investment Holdings (BDMDW) Notes Payables (2023 - 2025)

Baird Medical Investment Holdings has reported Notes Payables for 3 years, with the latest figure at $10.4 million in Q4 2025.

• For the quarter ending Q4 2025, Notes Payables fell 35.47% year-over-year to $10.4 million; the trailing twelve-month figure through Dec 2025 stood at $10.4 million (down 35.47% YoY), and the FY2025 full-year result was $10.4 million, down 35.47% from the prior year.
• Notes Payables for Q4 2025 stood at $10.4 million, down from $14.0 million in the prior quarter.
• The five-year high for Notes Payables was $16.2 million in Q4 2024, with the low at $8.2 million in Q4 2023.
• Average Notes Payables over 3 years is $12.2 million, with a median of $12.2 million recorded in 2025.
• Year-over-year, Notes Payables jumped 97.96% in 2024 and slumped 35.47% in 2025.
• Tracing BDMDW's Notes Payables over 3 years: stood at $8.2 million in 2023, then jumped by 97.96% to $16.2 million in 2024, then tumbled by 35.47% to $10.4 million in 2025.
• The last three Notes Payables figures came in at $10.4 million (Q4 2025), $14.0 million (Q2 2025), and $16.2 million (Q4 2024), per Business Quant data.

Peer Comparison